Adult Synovial Sarcoma

11 clinical trials · Condition

Record	Firm	Date
NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (NCT02059850)	Fred Hutchinson Cancer Center	2014-07-01
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma (NCT01532687)	OHSU Knight Cancer Institute	2012-03-13
Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery (NCT01477021)	Fred Hutchinson Cancer Center	2012-01-01
Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma (NCT01281865)	National Cancer Institute (NCI)	2011-01-01
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452)	National Cancer Institute (NCI)	2010-06-01
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors (NCT00831844)	National Cancer Institute (NCI)	2009-01-01
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma (NCT00720174)	National Cancer Institute (NCI)	2008-06-01
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma (NCT00346164)	Children's Oncology Group	2007-02-05
Ixabepilone in Treating Young Patients With Refractory Solid Tumors (NCT00331643)	National Cancer Institute (NCI)	2006-04-01
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma (NCT00245102)	National Cancer Institute (NCI)	2005-09-01
Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma (NCT00112463)	National Cancer Institute (NCI)	2005-01-07

Track Adult Synovial Sarcoma automatically

Every clearance here is in the API, with alerts when new ones post.